Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?

New improved methods are required for the early detection of esophageal adenocarcinoma in order to reduce mortality from this aggressive cancer. In this review we discuss different screening methods which are currently under evaluation ranging from image-based methods to cell collection devices coup...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Donovan, Maria, Fitzgerald, Rebecca C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061133/
https://www.ncbi.nlm.nih.gov/pubmed/29995243
http://dx.doi.org/10.1007/s10620-018-5192-3
_version_ 1783342158162427904
author O’Donovan, Maria
Fitzgerald, Rebecca C.
author_facet O’Donovan, Maria
Fitzgerald, Rebecca C.
author_sort O’Donovan, Maria
collection PubMed
description New improved methods are required for the early detection of esophageal adenocarcinoma in order to reduce mortality from this aggressive cancer. In this review we discuss different screening methods which are currently under evaluation ranging from image-based methods to cell collection devices coupled with biomarkers. As Barrett’s esophagus is a low prevalence disease, potential screening tests must be applied to an enriched population to reduce the false-positive rate and improve the cost-effectiveness of the program.
format Online
Article
Text
id pubmed-6061133
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-60611332018-08-09 Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible? O’Donovan, Maria Fitzgerald, Rebecca C. Dig Dis Sci Review New improved methods are required for the early detection of esophageal adenocarcinoma in order to reduce mortality from this aggressive cancer. In this review we discuss different screening methods which are currently under evaluation ranging from image-based methods to cell collection devices coupled with biomarkers. As Barrett’s esophagus is a low prevalence disease, potential screening tests must be applied to an enriched population to reduce the false-positive rate and improve the cost-effectiveness of the program. Springer US 2018-07-11 2018 /pmc/articles/PMC6061133/ /pubmed/29995243 http://dx.doi.org/10.1007/s10620-018-5192-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
O’Donovan, Maria
Fitzgerald, Rebecca C.
Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?
title Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?
title_full Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?
title_fullStr Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?
title_full_unstemmed Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?
title_short Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?
title_sort screening for barrett’s esophagus: are new high-volume methods feasible?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061133/
https://www.ncbi.nlm.nih.gov/pubmed/29995243
http://dx.doi.org/10.1007/s10620-018-5192-3
work_keys_str_mv AT odonovanmaria screeningforbarrettsesophagusarenewhighvolumemethodsfeasible
AT fitzgeraldrebeccac screeningforbarrettsesophagusarenewhighvolumemethodsfeasible

Ejemplares similares